Scottish Researchers, IBM Team on Supercomputing for HIV Research | GenomeWeb
NEW YORK (GenomeWeb News) – The University of Edinburgh has entered into a collaboration with the IBM Watson Research Center and the National Physical Laboratory, in Middlesex, to use supercomputers to study surface proteins of HIV-1 with the goal of developing drugs that inhibit HIV infection.
 
The University of Edinburgh said yesterday that knowing the structure and behavior of certain peptides will allow researchers to develop drugs that target the infection process.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.